The Food and Drug Administration took a crucial step toward approving the first treatment using the revolutionary gene-editing technique known as CRISPR to treat sickle cell disease.
×
The Food and Drug Administration took a crucial step toward approving the first treatment using the revolutionary gene-editing technique known as CRISPR to treat sickle cell disease.